MENU
+Compare
PJP
ETF ticker: NYSE ARCA
AS OF
Dec 3, 04:57 PM (EDT)
Price
$105.40
Change
+$1.46 (+1.40%)
Net Assets
308.01M

PJP stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index... Show more

Category: #Health
PJP
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for PJP with price predictions
Nov 28, 2025

Aroon Indicator for PJP shows an upward move is likely

PJP's Aroon Indicator triggered a bullish signal on November 28, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 238 similar instances where the Aroon Indicator showed a similar pattern. In of the 238 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for PJP just turned positive on October 31, 2025. Looking at past instances where PJP's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PJP advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PJP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PJP broke above its upper Bollinger Band on November 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Abbott Laboratories (NYSE:ABT), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Pharmaceutical IntellidexSM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.

Market Cap

The average market capitalization across the Invesco Pharmaceuticals ETF ETF is 102.86B. The market cap for tickers in the group ranges from 766.03M to 946.83B. LLY holds the highest valuation in this group at 946.83B. The lowest valued company is GERN at 766.03M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Pharmaceuticals ETF ETF was 7%. For the same ETF, the average monthly price growth was 34%, and the average quarterly price growth was 127%. GERN experienced the highest price growth at 6%, while JAZZ experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the Invesco Pharmaceuticals ETF ETF was -63%. For the same stocks of the ETF, the average monthly volume growth was -78% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 55
Price Growth Rating: 38
SMR Rating: 63
Profit Risk Rating: 53
Seasonality Score: 21 (-100 ... +100)
View a ticker or compare two or three
PJP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Powershares Exchange Traded Fund Trust227 E Prairie AveWheaton
Phone
N/A
Web
www.invescopowershares.com